Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Waters Corporation launches NuGenesis Lab Management System
Powerful alternative to LIMS offers seamless lab-to-business connection for science-driven organisations
DTAB receives leadership in Animal Welfare Award
Recommended a ban on the import of cosmetics tested on animals as well as the manufacture and sale of oxytocin
Battling on Different Fronts
The pharma sector in Maharashtra is facing challenges from different quarters, including bureaucratic hurdles, unwarranted…
’Maharashtra is the hub of quality medicines’
Maharashtra still dominates the Indian pharma sector, emphasises Mahesh Zagade, Commissioner, FDA Maharashtra, in conversation…
Glenmark consolidated revenue increases by 27.53% to Rs. 17,035.60 million in Q4 FY 2013-14
EBITDA grew by 46.7 per cent to Rs 3816.17 millionGlenmark Pharmaceuticals announced its full year results for the year ended…
’Pharmaceuticals contribute 30 per cent to Ireland’s exports’
Ireland holds a formidable position on the global pharmaceutical map not only being home to nine out of ten pharma companies but…
Boehringer Ingelheim sees increase in operating income and return on net sales
Net sales of around €14.1 billion achieved